However, the high specificity (95.2%) is a strong argument to consider serum KL-6 a marker of fibrosis, potentially serving as a valuable tool for monitoring the progression of pulmonary fibrosis in patients already diagnosed with silicosis. This evidence concerns the gene MUC1 and pulmonary fibrosis.